Celltrion applied for European approval of biosimilar antibody for the second time
On the 11th, Celltion announced the European Medicines Agency(EMA) received the document for the approval application of CT-P10 on the 10th of November(local time).
Since the company has followed the same approval process, the EMA Centralized procedure, as the first products entered to the Europ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
